At this year’s SRI, a few themes popped up in panels across a range of topics: disclosure trends; governance priorities; and frequently discussed interpretive questions.
IPO Comment Letter Timing: Still Long, but Improving
Initial comment letters for IPOs are still currently taking longer than the 30-day target reflective of both filing volume and working down
Corporate & Commercial
FDA and EMA Provide Guiding Principles for AI in Drug Development
On Jan. 14, 2026, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) jointly released the “Guiding Principles of Good AI Practice in Drug Development,” a set of 10 high-level principles intended to steer the safe and responsible use of AI across the product lifecycle. While not formal industry guidance, the…
At a Crossroads- Issue #2: Legal Risk as a Tool for Navigating Supply Chain Volatility: Observations from the Semiconductor Industry at the Beginning of 2026
Please contact: Tim Flamank or Francesco Liberatore with any questions.
Supply chain disruption remains a key risk in the semiconductor industry. Recent events have shown that even beyond high-tech corners of the sector, supply and demand dynamics over critical components, expertise and end products can change quickly and dramatically. The consequences for the automotive industry…
FTC Updates (January 12 – 16, 2026)
As we enter the new year, the FTC continues to prioritize consumer protection and fair competition, taking significant steps to prosecute offenders for alleged misleading conduct regarding consumer consent and enforce existing court orders. Additionally, the FTC has announced multiple revisions to the jurisdictional thresholds under the Clayton Act, increasing the thresholds for premerger notification…
Thoughts on Managing the AI Transformation
The following is part of our annual publication Selected Issues for Boards of Directors in 2026. Explore all topics or download the PDF.
Over the last nine years, during which I served as Cleary Gottlieb’s Managing Partner, there have been significant, often unexpected, changes in global politics, global markets and the legal industry.…
M&A: 2025 in Review and a Look Ahead to 2026
The following is part of our annual publication Selected Issues for Boards of Directors in 2026. Explore all topics or download the PDF.
At the end of 2024, predictions across the dealmaking industry were broadly optimistic: due to an anticipated combination of loosening financial conditions, a pro-deal regulatory environment from a change in administration and…
Whistleblowing in Focus: Recent Developments, Emerging Issues, and Considerations for Companies (Part Three: Looking Ahead)
Introduction[1]
In this three-part series, we first discuss the outlook for whistleblower programs in the United States under the new administration. Second, we review initiatives relating to whistleblower reports in other jurisdictions over the past year. Third, we address emerging issues and considerations for companies regarding whistleblower reports.…
The Open Questions in U.S. Generative AI Copyright Litigation
The following is part of our annual publication Selected Issues for Boards of Directors in 2026. Explore all topics or download the PDF.
Overview of AI Copyright Litigation
In 2026, we can expect important developments in the legal landscape of generative AI and copyright. Dozens of copyright infringement lawsuits targeting the training and development of…
Managing AI Risk: Legal and Governance Imperatives for the Board
The following is part of our annual publication Selected Issues for Boards of Directors in 2026. Explore all topics or download the PDF.
AI adoption is now mainstream: 88% of businesses use AI in at least one function, with global spending expected to exceed $1.5 trillion in 2025 and approach $2 trillion in 2026. As…
Corporate Fraud and Institutional Liability in the Age of Deepfakes
When discussing the litigation challenges deepfake technology poses, one typically thinks of difficulties protecting individual privacy rights, complications prosecuting anonymous actors, the lack of law regulating deepfake usage outside commercial context, and authentication and evidentiary issues. Less prevalent is a discussion of potential liability companies face for fraud perpetrated on their customers. Yet, the proliferation of…